Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,Hematology
Reference34 articles.
1. National Comprehensive Cancer Network. Non- Small Cell Lung Cancer. Version 3.2018. https://www.nccn.org/professionals/physician_gls/pdf/nsclc.pdf. Accessed April 5, 2018.
2. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study;Onishi;J Thorac Oncol,2007
3. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010
4. Stereotactic radiotherapy versus surgery for early-stage operable lung cancer: more questions than answers;Verma;J Natl Compr Canc Netw,2015
5. Efficacy and toxicity analysis of NRG Oncology/ RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC);Bezjak;Int J Radiat Oncol Biol Phys,2016
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis;Clinical Oncology;2024-07
2. Acute Large Dose Irradiation Sensitizes Surviving Cells to Subsequent Irradiation; Implications for Stereotactic Body Radiation Therapy;Radiation Research;2024-03-08
3. Outcome of conventional radiotherapy in small centrally located tumours or lymph nodes: minimal toxicity, remarkable survival but challenging loco-regional control;Acta Oncologica;2023-09-14
4. Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience;International Journal of Radiation Oncology*Biology*Physics;2023-07
5. Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre;Cancers;2023-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3